[The Hepatitis B Vaccination Campaign Carried out from 1982 to 1984 Using the Hevac B Pasteur Vaccine Among 6162 Employees of Vaud Hospitals]
Overview
Authors
Affiliations
6162 Swiss hospital employees were vaccinated against hepatitis B from 1982-1984 with Hevac B Pasteur vaccine. Vaccination was offered free of charge to 8471 employees, 72% of whom accepted a series of three injections and 50% a booster about 15 months later. Side effects, all benign, brief and rapidly resolved, were observed after 4% of injections in 7% of patients. Side effects after each of the three injections were noted in 0.7% of subjects. These figures are below those of other authors. -Concentrations of protective anti-HBs antibodies produced by the vaccination were measured by sampling of subjects. Four years after the beginning of the vaccinations the subjects had an average concentration of 87 mU/ml without booster and 595 mU/ml with booster. On average these concentrations are higher in employees more heavily exposed to hepatitis B than in the others. They are also higher in vaccines than in subjects immunized after natural infection, in whom they were 138 mU/ml. Production of anti-HBs antibodies was observed in 94% of subjects vaccinated.-In conclusion, the preparation used proved effective and well tolerated. This observation should help to foster more general use of vaccination campaigns in exposed populations.
Bucher B, Francioli P, Geudelin B, Fritzell B, Lavanchy D, Frei P Eur J Clin Microbiol Infect Dis. 1994; 13(3):212-7.
PMID: 8050433 DOI: 10.1007/BF01974539.